A US appeals court has upheld a previous ruling invalidating Lilly's method-of-use patent for its anticancer, Gemzar (gemcitabine HCl for injection).
The ruling is expected to clear the path for the entry of cut-price generic versions of Gemzar ...
A US federal judge has decided to hold a hearing on 17 August relating to Sanofi-Aventis 's lawsuit, which "seeks a temporary restraining order and a preliminary injunction requiring [the US] FDA to withdraw its approval" of the ANDA for Sandoz ...
The US FDA approval of the first generic version of Sanofi-Aventis's Lovenox (enoxaparin sodium) to Novartis ' generics arm Sandoz, which uses technology from Momenta Pharmaceuticals , has caused a buzz because the agency has treated the application ...
GlaxoSmithKline 's recent announcement that a legal charge for the second quarter of $2.36 billion included $750 million to dispose of a government probe into the company's former manufacturing site at Cidra, Puerto Rico, might have come as a ...
GlaxoSmithKline's £1.57 billion legal charge to resolve Avandia (rosiglitazone) lawsuits and restructuring charges caused the UK company to post a loss of 6 pence per share in the second quarter.
The charge, which is to cover settlements, ...
